Cargando…

Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology

Increasing evidence suggests that hyperphosphorylation and aggregation of microtubule-associated protein tau (MAPT or tau) correlates with the development of cognitive impairment in Alzheimer’s disease (AD) and related tauopathies. While numerous attempts have been made to model AD-relevant tau path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maphis, Nicole M., Jiang, Shanya, Binder, Jessica, Wright, Carrie, Gopalan, Banu, Lamb, Bruce T., Bhaskar, Kiran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355442/ https://www.ncbi.nlm.nih.gov/pubmed/28367114 http://dx.doi.org/10.3389/fnmol.2017.00069

Ejemplares similares

Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
por: Jiang, Shanya, et al.
Publicado: (2020)

Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
por: Maphis, Nicole, et al.
Publicado: (2016)

Genetically enhancing the expression of chemokine domain of CX(3)CL1 fails to prevent tau pathology in mouse models of tauopathy
por: Bemiller, Shane M., et al.
Publicado: (2018)

Loss of tau rescues inflammation-mediated neurodegeneration
por: Maphis, Nicole, et al.
Publicado: (2015)

Machine learning prediction and tau-based screening identifies potential Alzheimer’s disease genes relevant to immunity
por: Binder, Jessica, et al.
Publicado: (2022)

Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
por: Weston, Lea L., et al.
Publicado: (2021)

Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
por: Maphis, Nicole M., et al.
Publicado: (2019)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
por: Bemiller, Shane M., et al.
Publicado: (2017)

Seed-competent tau monomer initiates pathology in a tauopathy mouse model
por: Mirbaha, Hilda, et al.
Publicado: (2022)

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
por: Horie, Kanta, et al.
Publicado: (2022)

A simple human cell model for TAU trafficking and tauopathy-related TAU pathology
por: Bell, Michael, et al.
Publicado: (2021)

Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model
por: Lauretti, E, et al.
Publicado: (2017)

Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway
por: Jiang, Shanya, et al.
Publicado: (2021)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

APOE ε2 is associated with increased tau pathology in primary tauopathy
por: Zhao, Na, et al.
Publicado: (2018)

Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
por: Sankaranarayanan, Sethu, et al.
Publicado: (2015)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2019)

The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
por: Stancu, Ilie Cosmin, et al.
Publicado: (2022)

Hippocampal Synaptic Alterations Associated with Tau Pathology in Primary Age-Related Tauopathy
por: Morris, Meaghan, et al.
Publicado: (2023)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
por: Šimić, Goran, et al.
Publicado: (2016)

Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
por: Wang, Xiaohai, et al.
Publicado: (2018)

The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2017)

Atrophy associated with tau pathology precedes overt cell death in a mouse model of progressive tauopathy
por: Fung, Christine W., et al.
Publicado: (2020)

Analysis of in vivo turnover of tau in a mouse model of tauopathy
por: Yamada, Kaoru, et al.
Publicado: (2015)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2020)

The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology
por: Mah, Dylan, et al.
Publicado: (2021)

Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy
por: Mate, Veronika, et al.
Publicado: (2022)

Transcriptional Signatures of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer’s Disease
por: Stein-O’Brien, Genevieve L, et al.
Publicado: (2023)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Nmnat1 protects neuronal function without altering phospho‐tau pathology in a mouse model of tauopathy
por: Musiek, Erik S., et al.
Publicado: (2016)

CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
por: Joly-Amado, Aurelie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8v3e04dd9lb1vm7st1p4qm7iev